Spinal taps open a window on alcohol use disorder

NCT ID NCT06286449

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 10, 2026 · Updated 1 time

Summary

Researchers at Sahlgrenska University Hospital are collecting cerebrospinal fluid through lumbar puncture from people with alcohol use disorder and from healthy volunteers across different ages. They will measure molecules such as dopamine and test how the fluid affects nerve cell excitability and synapse formation in the lab. The goal is to understand the brain mechanisms behind alcohol use disorder and build a healthy reference group for comparison, which could guide future drug development.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
lumbar puncture (spinal tap) for cerebrospinal fluid collection
What this could lead to
If the study identifies key molecules in spinal fluid that drive alcohol use disorder, it could point researchers toward new medications for a condition with few effective drug options.
What could go wrong
This is an early observational study with about 50 participants, so it cannot prove cause or produce a treatment by itself. A spinal tap carries small risks of headache, bleeding, or infection, and the findings may not translate into new therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: The study participant: 1. has given his/her written and oral informed consent to participate in the study 2. presents a breath alcohol concentration (BrAC) below 10mg% (10mg/dl) at the study visit Exclusion Criteria: The study participant: 1. is pregnant or breastfeeding 2. has an ongoing neurological or psychiatric disease except for Alcohol Use Disorder 3. has an ongoing or previous disease that affects either the safety of the study participant following a spinal tap or the outcome measures of the study 4. currently uses (within 30 days of enrollment) medication that affects either the safety of the study participant following a spinal tap or the outcome measures of the study 5. currently uses (within 30 days of enrollment) medications for the treatment of Alcohol Use Disorder or alcohol abstinence that affects the mesolimbic dopamine system 6. currently uses (within 30 days of enrollment) dietary supplements, including energy drinks, that may affect the safety for the study participant following a spinal tap or may have an impact on the outcome measures 8\. currently and frequently uses (within 1 year of enrollment) drugs of abuse other than alcohol and nicotine. 9\. participates in another interventional clinical trial within 30 days of enrollment 10\. has a local infection or a tattoo in the lower back region 11\. anatomical anomalies in the lower spine region, e.g. following prior spine surgery, that obstructs the procedure of a spinal tap 12\. has prior history of allergic reactions to local anaesthetics 13\. presents pathological findings during medical examination that may affect the safety for the study participant following a spinal tap or the outcome measures 14\. is considered to be unfit for study participation for other reasons than stated above

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol use disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sahlgrenska Universitetssjukhuset

    Gothenburg, Västra Götaland County, 405 30, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.